Nucleic Acid Amplification Testing Market

1. Nucleic Acid Amplification Testing Market Nucleic Acid Amplification Testing Market Size Worth USD 28.86 Billion by 2034 | CAGR: 12.1% Nucleic Acid Amplification Testing Market Size, Share, & Industry Analysis Report: By Type (PCR Tests, INAAT Tests, and LCR Tests), By Application, By End Use, and By Region – Market Forecast, 2025–2034

3. Nucleic Acid Amplification Testing Market • The nucleic acid amplification testing market size was valued at USD 9.15 billion in 2024. It is projected to grow from USD 10.24 billion in 2025 to USD 28.86 billion by 2034, exhibiting a CAGR of 12.1% during 2025–2034. Request To Sample : https://www.polarismarketresearch.com/industry-analysis/nucleic- acid-amplification-testing-market/request-for-sample

4. Nucleic Acid Amplification Testing Market • Key Market Players : • Abbott Laboratories • Agilent Technologies, Inc. • Becton, Dickinson and Company (BD) • bioMérieux S.A. • Danaher Corporation (Cepheid) • F. Hoffmann-La Roche AG • Hologic, Inc. • Illumina, Inc. • QIAGEN N.V. • Siemens Healthineers AG • Thermo Fisher Scientific Inc.

5. Nucleic Acid Amplification Testing Market Nucleic Acid Amplification Testing Market Report Highlights • By type, the polymerase chain reaction (PCR) tests segment held the largest share globally in 2024 due to their high specificity, sensitivity, and broad applicability across various diagnostic areas. Isothermal nucleic acid amplification technology (INAAT) tests are anticipated to exhibit the highest growth rate during the forecast period, driven by the increasing demand for rapid and point-of-care testing solutions. • By application, the infectious disease testing segment constituted the largest application segment in 2024, fueled by the widespread use of NAAT for diagnosing and monitoring a wide array of infectious agents. Oncology testing is expected to be the fastest-growing application segment, driven by the increasing adoption of molecular diagnostics in cancer management and personalized medicine approaches. • By end use, the central and reference laboratories segment accounted for the largest share of the nucleic acid amplification testing market in 2023, attributed to the high volume of tests processed in these facilities and their role as key hubs for specialized testing. The hospitals segment is projected to demonstrate the highest growth rate, driven by the increasing integration of advanced molecular diagnostics within hospital settings for rapid and improved patient care. Buy Now : https://www.polarismarketresearch.com/buy/4683/0

6. ????? ??: Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. ??????? ????: Polaris Market Research Phone: +1-929-297-9727 Email: sales@polarismarketresearch.com